Search for: "Allergan Plc" Results 21 - 40 of 40
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Jan 2017, 8:26 am by Molly Crabtree
  It is well-known that the DOJ has been investigating generic drug companies for approximately two years, and as a result of the disclosure of those investigations, shareholder class action lawsuits began being filed in November 2016 against manufacturers Endo International, plc, Allergan plc, and various predecessors and executives. [read post]
21 Dec 2016, 7:18 am by Gene Quinn
The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) recently instituted six separate inter partes reviews (IPRs) against patents owned by Allergan plc (NYSE: AGN), which cover RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%. [read post]
13 Dec 2016, 4:15 am by Gene Quinn
Last week the Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) instituted six separate inter partes reviews (IPRs) against patents owned by Allergan plc, which cover RESTASIS®. [read post]
8 Nov 2016, 11:53 pm by Kevin LaCroix
  First, on November 4, plaintiffs’ lawyers filed a securities class action lawsuit in the Central District of California against Allergan plc, Allergan’s predecessor company Actavis plc, and certain of its Allergan’s directors and officers. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
The complaint also names Allergan plc, the parent company of Watson, and Endo International plc, the parent company of Endo Pharmaceuticals Inc. [read post]
6 Apr 2016, 7:37 pm by Consuella Pachico
Pfizer Inc. and Allergan PLC withdrew their planned $160 billion merger, ending what would have been the largest so-called inversion transaction. [read post]
21 Dec 2015, 3:00 am by Paul Caron
Marian (UC-Irvine), Inversions and Competitiveness: Reflections in the Wake of Pfizer/Allergan: The recent announcement that Pfizer Inc. has reached a merger agreement with Allergan PLC , with the combined entity being tax-resident in Ireland, is a good occasion to reconsider U.S. policy options... [read post]
30 Nov 2015, 6:11 am
The situation, which ultimately resulted in the acquisition of Allergan by Actavis plc, included a novel structure that involved a “partnership” between Valeant and the investment fund Pershing Square. [read post]
23 Nov 2015, 2:05 pm by Ben Vernia
Sales LLC, a subsidiary of pharmaceutical manufacturer Warner Chilcott PLC, has agreed to plead guilty to a felony charge of health care fraud, the Justice Department announced today. [read post]
15 Nov 2015, 9:32 pm by Patent Docs
.; Allergan PLC Infringement of U.S. [read post]
10 Sep 2015, 5:47 pm by Lawrence B. Ebert
Flash forward one hundred or so years and look at the recent Pfizer case in England:From Bloomberg:Pfizer Inc. was accused by a U.K. judge of making “groundless threats” of legal action against British doctors and drugstores if they prescribed or sold a generic version of its best-selling Lyrica treatment.Judge Richard Arnold issued the rebuke as he ruled that Allergan Plc’s Actavis unit didn’t infringe Pfizer patents with its version of the drug… [read post]
19 Apr 2015, 9:56 pm by Patent Docs
• Defendants: Allergan, Inc.; Actavis, PLC.; Allergan Sales, LLC Infringement of U.S. [read post]
21 Mar 2015, 6:26 am by Lawrence B. Ebert
Actavis plc (NYSE:ACT), No. 1:14-cv-00882 (D. [read post]
On November 17, 2014, Allergan, Inc. announced a $66 billion merger agreement with Actavis plc, thwarting the pending $53 billion bid for Allergan by Valeant Pharmaceuticals International Inc. [read post]
9 Mar 2014, 9:31 pm by Patent Docs
Actavis plc et al. 2:14-cv-00188; filed March 6, 2014 in the Eastern District of Texas • Plaintiff: Allergan, Inc. [read post]
4 Nov 2011, 4:09 am by John Hopkins
GlaxoSmithKline PLC has agreed to pay the US government $3 billion to settle allegations that it violated marketing practices and may have defrauded Medicaid. [read post]
1 Sep 2010, 2:25 pm
This consumer protection information is provided by Louisville, Kentucky attorney Will Nefzger, a partner at Bahe Cook Cantley & Jones PLC. [read post]